Julius Asubonteng, PhD

Director
Regeneron

Poster(s):

• (063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (132) A Framework for Rapid Analysis of Real-World Data in Safety Signal Assessment
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (172) Feasibility Assessment of Hypertension among Patients with Diabetic Macular Edema using Real World Data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (299) Assessing the agreement between open and closed medical claims in a rare disease cohort
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (BSPOT38) Estimating period prevalence: comparing methods to describe a rare disease population
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST